Sarocladium kiliense, formerly known as Acremonium kiliense, 1 is an omnipresent soil saprophytic fungus generally found in the environment such as cereal fields and the soils of grass lands, and sporadically infecting humans and other mammals. [2][3][4] The species of Sarocladium are morphologically very homologous and in the most of the clinical cases the causative agent is reported only as a Sarocladium/Acremonium sp., which dramatically decreases the value of the investigations. 5 This is the principal cause that the actual incidence of the various species of Sarocladium in the clinical setting is unknown. Molecular identification of Sarocladium using modern DNAbased techniques is essential for a critical assessment of the reported cases. This fungus can cause opportunistic infections, such as mycetoma, onychomycosis, fungal keratitis, in immunocompetent individuals, and osteomyelitis, pneumonia, arthritis, peritonitis, endocarditis, meningitis, and sepsis in immunocompromised patients. 6,7 The main risk factors are considered as the use of catheters and prosthesis, anatomic disorders, immunosuppressive therapy, autoimmune diseases, diabetes mellitus, and malignancies. 2,8 Here, we present a systemic case of S. kiliense in a diabetic patient infected to coronavirus disease 2019 (COVID-19) from Isfahan, Iran.
| CASE PRESENTATIONA 74-year-old woman with 25 years history of diabetes mellitus was referred to a private traditional medicine center